JESSICA CUEN: Open Payments
NPI 1801267083 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,055 in 87 payments from 28 companies in 2025. Trend: 2023 $1,221 · 2024 $1,269 · 2025 $3,055
Food & beverage: $3,055
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $530 |
| Corcept Therapeutics | 12 | $473 |
| AstraZeneca Pharmaceuticals LP | 6 | $361 |
| Otsuka America Pharmaceutical, Inc. | 10 | $278 |
| Novo Nordisk Inc | 9 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $182 |
| CeQur Corporation | 1 | $165 |
| Madrigal Pharmaceuticals | 1 | $104 |
| Edwards Lifesciences Corporation | 1 | $82 |
| SHIELD THERAPEUTICS INC | 1 | $59 |
Products named: Korlym, LINZESS, AIRSUPRA, REXULTI, Kerendia, CeQur Simplicity, Ozempic, Wegovy.
Industry payments across CA — which companies pay providers there.
